All News

Systematic reviews and abstracts for randomized controlled trials (RCTs) appearing in the urologic literature are generally of less than optimal quality, say researchers from the University of Florida College of Medicine, Gainesville.

It is vital for urologists to take time out of their busy day to contact committee chairs and committee members or, better yet, testify when a bill in committee affects how urologists treat their patients.

There are different ways to go about billing for a locum tenens depending on your circumstances.

These tough economic times may give you pause if you're in the market to buy or sell a practice. But buying or selling at the right price at the right time could be the best investment you will ever make.

Urologists share their thoughts on hiring a practice consultant.

Supplies in your practice may cost more than you think.

Once again, we face a Medicare payment update for the new year that raises a number of questions, the answers to which are not favorable to practicing urologists.

Nerve growth factor (NGF) levels in urine could prove a useful biomarker for interstitial cystitis/painful bladder syndrome (IC/PBS) and neurogenic overactive bladder.

Over the course of a decade, the therapeutic pendulum in treating urinary incontinence in women swung dramatically from needle suspension and anterior urethropexy to collagen injections and back again to suspension procedures with no sound clinical trials driving the move toward either approach.

Roswell Park Cancer Institute has appointed Thomas Schwaab, MD, PhD, as staff physician and assistant professor of oncology in the departments of urology and immunology. Dr. Schwaab offers laparascopic and robot-assisted surgery to patients with kidney cancer and other genitourinary cancers.

A new national clinical trial will test whether testosterone therapy can favorably affect certain conditions that occur in older men.

PSA screening has reduced prostate cancer mortality up to 31%, according to findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

AUA, as part of a coalition of 18 other surgical specialties, said it is urging the U.S. Senate to consider making critical changes to its version of the Patient Protection Affordable Care Act of 2009 to address significant concerns from physician groups.

Merck & Co. has released iPhone applications for the professional and consumer editions of its Merck Manual.

Having trouble with a patient who refuses to pay his account balance? Learn about your options.

Management consultant Keith Borglum, CHBC, offers some tips on keeping the appointment calendar full.

Educate your patients about urinary tract infection with a free, customizable handout.

In children with recurrent urinary tract infections, low-dose, continuous oral antibiotic therapy may help prevent future recurrences.

Using an extremely sensitive tool based on nanotechnology, researchers from Northwestern University, Chicago say they have detected previously undetectable levels of PSA in patients who have undergone radical prostatectomy.

The FDA has approved GlaxoSmithKline's pazopanib (Votrient) to treat patients with advanced renal cell carcinoma.

More than 85,000 physicians and other eligible professionals who successfully reported quality-related data to Medicare under the 2008 Physician Quality Reporting Initiative (PQRI) received incentive payments totaling more than $92 million, significantly above the $36 million paid in 2007, according to the Centers for Medicare & Medicaid Services.

Two investigational oral phosphodiesterase type-5 inhibitors for the treatment of erectile dysfunction have shown positive results in separate studies.

Despite a national focus on reducing surgical errors, surgery-related adverse events continue to occur both inside and outside the operating room, according to a recent analysis of events at Veterans Health Administration Medical Centers.

The potential benefits of shock wave lithotripsy (SWL) outweigh the foreseeable risks of this treatment, according to a recently released white paper from AUA.

The U.S. House of Representatives has passed a bill that would abandon the current Medicare physician payment formula and allow future rates to increase based more closely on physicians? costs, a revision that is expected to cost approximately $210 billion over 10 years.

With guidance from the American Association of Clinical Urologists, Inc., urologists have scored key grassroots victories in state legislatures across the country over the past year.